The gluten-free diet is the only treatment celiac disease has—but for a significant portion of patients, it’s not enough. Symptoms persist. Inflammation continues. A new review published this week in Autoimmunity Reviews may explain part of why: celiac disease doesn’t just damage the intestine—it fundamentally disrupts the gut microbiome, the community of trillions of bacteria that live in the digestive tract. And that disruption doesn’t reliably reverse when patients go gluten-free.
The review, by Fotios Fousekis and colleagues from institutions in Germany and Greece, synthesizes current research on how celiac disease alters gut bacteria, how those alterations contribute to the disease process, and what they suggest for treatments beyond dietary restriction. The conclusions are important for celiac families to understand—because they reframe the gluten-free diet not as the whole solution, but as one essential piece of a more complicated picture.
What This Means for You
If someone you love follows a strict gluten-free diet and still doesn’t feel well, the microbiome may be part of the answer. Research shows that celiac disease is associated with a characteristic pattern of gut bacterial disruption—and that this disruption can persist even after gluten is removed from the diet. The bacteria that should be there aren’t; bacteria that cause problems are more abundant than they should be.
This matters for two reasons. First, it may help explain persistent symptoms—the ongoing fatigue, bloating, and gut discomfort that some celiac patients experience despite careful adherence to a gluten-free diet. We covered one piece of this puzzle earlier when a study pointed to microbial overgrowth as a driver of lingering symptoms. The Fousekis review builds on that picture, framing microbiome disruption not as a side effect of celiac disease but as a factor that may actively sustain it.
Second—and this is where the review gets genuinely exciting—it opens the door to new therapeutic targets. If the microbiome is a driver of disease activity, then restoring it becomes a treatment goal, not just a side benefit. That puts interventions like probiotics, dietary adjustments that specifically support beneficial bacteria, and even fecal microbiota transplantation (FMT) on the table as potential complements to the gluten-free diet.
As a parent raising a child with celiac disease, I pay close attention to research like this. The gluten-free diet is a lifelong commitment that touches every meal, every social event, every school lunch. If the science tells us it may not fully heal the gut on its own, then understanding what else can help matters enormously.
Key Takeaways
- Celiac disease alters the gut microbiome in a consistent and measurable way—not just as a consequence of intestinal damage, but potentially as a factor that drives ongoing inflammation.
- The gluten-free diet improves but does not always restore a healthy microbiome.
- Persistent symptoms in adherent celiac patients may be partly explained by microbiome imbalance.
- Probiotic and microbiome-targeted therapies are emerging as research priorities for celiac treatment.
- This review signals that future celiac care may combine dietary management with microbiome restoration strategies.
The Science
Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No medical degree required.
What Is the Gut Microbiome and Why Does It Matter in Celiac Disease?
The gut microbiome refers to the community of microorganisms—primarily bacteria—that live in the digestive tract. A healthy microbiome is diverse and balanced, contributing to digestion, immune regulation, and the integrity of the intestinal lining. In celiac disease, the immune system mounts an abnormal response to gluten (a protein found in wheat, rye, and barley), which damages the villi—the small finger-like projections lining the small intestine that absorb nutrients.
What the Fousekis review highlights is that this damage doesn’t happen in a microbial vacuum. The gut microbiome both influences and is influenced by celiac-related inflammation, creating a feedback loop that the gluten-free diet addresses only partially.
What Changes in the Celiac Microbiome?
Celiac disease is consistently associated with dysbiosis—an imbalance in the normal composition of gut bacteria. In practical terms, this means certain bacteria that are usually protective and abundant are reduced, while others that can promote inflammation become more prevalent.
Research summarized in this review points to lower levels of Lactobacillus and Bifidobacterium species—bacteria associated with gut health, immune regulation, and production of short-chain fatty acids (SCFAs, small molecules that help maintain the intestinal lining and dampen inflammation). At the same time, populations of Bacteroides, Prevotella, and certain proteobacteria—which can increase intestinal permeability and immune activation—are elevated in many celiac patients.
This matters because the gut bacteria aren’t passive bystanders. Lactobacillus species, for example, can help break down gluten peptides and modulate immune responses. When these bacteria decline, the intestinal environment may become more permissive to gluten-triggered immune activation.
The Microbiome and Disease Pathogenesis
Pathogenesis refers to how a disease develops and sustains itself. The review’s key contribution is framing microbiome disruption not just as a result of celiac damage, but as a potential amplifier of it.
Here’s the mechanism: celiac-related inflammation damages intestinal villi, which changes the local environment for gut bacteria—altering pH, nutrient availability, and immune signaling. This shifted environment favors bacteria that thrive in inflamed tissue. Those bacteria then produce compounds that further increase intestinal permeability (sometimes called “leaky gut”)—meaning more gluten fragments and bacterial products cross into the tissue where they can trigger immune responses. That immune activation causes more inflammation, which further disrupts the microbiome.
The result is a cycle that gluten removal can interrupt but may not fully break, particularly if the microbiome has been significantly altered.
This connects to research we covered from the University of Cincinnati showing that gut bacterial composition influences who develops celiac disease in genetically susceptible individuals—evidence that the microbiome plays a role from the beginning, not just after diagnosis.
What This Means for Treatment
The treatment implications are the most forward-looking section of the review. If dysbiosis contributes to ongoing disease activity, then correcting it becomes a therapeutic target alongside gluten avoidance.
Probiotic supplementation is the most studied intervention. Strains of Lactobacillus and Bifidobacterium have shown promise in reducing intestinal permeability, modulating immune responses, and improving symptom scores in celiac patients—though the evidence remains preliminary and strain-specific. Not all probiotics are equivalent, and the field hasn’t yet identified which strains, doses, or durations are optimal for celiac disease.
Prebiotic dietary interventions—consuming foods that selectively feed beneficial bacteria—are also under investigation. Dietary fiber, particularly inulin-type fructans (fermentable fibers found in vegetables like chicory, leeks, and onions), can selectively promote Bifidobacterium growth. The irony is that some of these vegetables cross-react with gluten in poorly managed kitchens, making implementation complicated for celiac families, but the principle is sound.
Fecal microbiota transplantation (FMT)—transferring gut bacteria from a healthy donor to a patient—remains experimental in celiac disease but is generating research interest given its success in other gut conditions like recurrent Clostridioides difficile infection.
None of these are ready to replace or even substantially supplement the gluten-free diet today. But the direction of the science is clear: celiac treatment is likely to expand beyond dietary management alone.
For families like mine, watching this research develop is both encouraging and sobering. Encouraging because it suggests that persistent symptoms after going gluten-free have an identifiable biological explanation—and potentially a biological solution. Sobering because it underscores how much the field still has to learn about a disease that currently has only one treatment, and a demanding one at that.
The Fousekis review is a synthesis, not a clinical breakthrough. But synthesis papers like this matter—they map what’s known, identify the gaps, and point toward where the next interventions should come from. That work is worth following closely.
Related Coverage
- Correction: Association of gut microbiota with lactose intolerance and coeliac disease: a two-sample Mendelian randomization study
- Persistent Celiac Symptoms? New Study Points to Microbial Overgrowth
- New study links gut makeup to celiac disease development – University of Cincinnati
References
Fousekis F, Lianos GD, Stavropoulou E, et al. Decoding gut microbiome alterations in celiac disease: Implications for pathogenesis and treatment. Autoimmunity Reviews. 2026 Jul 1:104127. doi: 10.1016/j.autrev.2026.104127. PMID: 42386020.